NexgenRx Announces Second Quarter Results, With Over 19% Revenue Growth and Positive EBITDA

TORONTO, ON / ACCESSWIRE / August 15, 2024 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the second quarter ended June 30, 2024, with quarterly revenue increasing to $4,084,839, and increased positive …
Jetzt den vollständigen Artikel lesen